Atamyo Therapeutics Presents Promising Results in the First Patients Treated With Its ATA-200 Gene Therapy in the Clinical Trial Targeting LGMD-R5 Limb-Girdle Muscular DystrophyMorningStar·May 14 at 04:45 AMNBSE.ESCFBT+0.87%
Valerio Therapeutics Announces the Launch of InVimmune, a New Company Dedicated to Developing Differentiated in Vivo Cell Therapy ApproachesMorningStar·May 4 at 02:05 AMNBSE.ESCTOVX-4.06%
Seaport and Hemab target $180m IPOs as biotech listings accumulatePharmaceutical Technology·Apr 28 at 05:22 AM426CVR015TMPCOEP0.00%
Kailera Therapeutics Announces Pricing of Initial Public Offering | KLRA Stock NewsStockTitan·Apr 16 at 10:30 AMKPTI+2.19%NBSE.ESC
Inhibitor Therapeutics Advances Gorlin Syndrome Itraconazole ProgramTip Ranks·Apr 1 at 08:08 AMIKT+3.17%TTRX+11.04%
Shield Therapeutics (LON:STX) Share Price Crosses Below 50-Day Moving Average - What's Next?Market Beat·Apr 1 at 03:53 AMSEELQ0.00%NBSE.ESC
Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome | INTI Stock NewsStockTitan·Mar 31 at 06:45 AMBIB+1.63%XBI+2.40%
Oncotelic Subsidiary Showcases Deciparticle Platform at BIO-EuropeTip Ranks·Mar 30 at 12:49 PMARKG+4.69%IHE-1.00%
